UNSPSC 51351913: Quingestanol

This classification denotes a norpregnadiene with the molecular formula C25H34O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1A635076CE, chemically known as 3-cyclopentyloxy-19-nor-3,5-pregnadien-20-in-17beta-ol but generally known as quingestanol, which bears US NIH Compound Identifier 25414. European Medicines Agency schedules Quingestanol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10216MIG.

UNSPSC 51351913 Quingestanol, a Commodity code, encompasses the supply of pharmaceutical active ingredients and finished-dose products to state and local health systems, with recent state and local activity focused on establishing framework agreements for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesale channels. State and local governments procure under this code to stock health department facilities, state university medical services, county hospitals, and other public health infrastructure with pharmaceutical inventory managed through cooperative purchasing alliances and direct vendor agreements. The issuing bodies are primarily state cooperative purchasing offices (such as multistate alliances administered by state departments of administration) that aggregate demand across multiple state and local member agencies, including counties and municipalities within their networks.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (solicitation number S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. This procurement requires vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health, and Morris & Dickson Co., LLC), maintain cGMP and DSCSA compliance, carry $5,000,000 commercial general liability insurance, and submit detailed product information including NDC codes, SKUs, and UPCs. Pricing is weighted at 75 percent of the evaluation, with compliance and administrative requirements accounting for the remainder. The contract term runs two years for new vendors with optional extensions, effective July 1, 2026, with awarded vendors subject to a 3 percent administrative fee on all contract purchases and performance penalties of $200 to $1,500 per violation. Geographic activity centers on the Upper Midwest and Pacific Northwest (Minnesota and Oregon specifically identified as participating members), with MMCAP reserving the right to make single, dual, or multi-awards based on therapeutic considerations and member-specific needs.